OMICS Group
International contributes to the scientific community through its Open
Access Initiative and OMICS Group Conferences. OMICS Group hosts over 350
leading-edge peer reviewed Open Access Journals which are supported by
more than 30000 eminent Editorial Board Members through a 21 Days rapid,
quality and quick review process. The enhanced feature of the websites
includes the language translations into French, Chinese, and Spanish. OMICS Publishing Group journals have over 3.5 million readers and organize over 100 International Conferences annually all over the world with the support of more than 150 scientific associations. OMICS Group Conferences conducts Scientific Conferences,
symposia, workshops, trade shows, exhibitions and world congresses by
bringing together people on a single platform thereby achieving and
enlightening the knowledge across the world.
OMICS Group Conferences invites all the participants across the globe to attend the 3rd International Conference and Exhibition on Biowaivers and Biosimilars during October 27-29, 2014 Hyderabad, India. The main theme of the conference is "Current Challenges and Opportunities in Cost Effective and Affordable Biosimilars" which covers a wide range of critically important sessions. Biowaivers & Biosimilars International Conference
2014 is the best platform for Pharma, CMOs, CROs, research institutes,
investors and industry stakeholders to meet, associate and discuss
current industry trends and establish business partnerships. The target
audience will be Vice Presidents, Directors, Heads of Departments in the
field of Intellectual Property, Business Development, Bioequivalence,
Regulatory/Legal Affairs, Research and Development and
pharmacovigilance. Biowaivers & Biosimilars International Conference
2014 will gather the experts in the biosimilar development,
manufacturing and commercialization decision makers from all over the
world. Biosimilars-2014 is collaborated with DPA (Doctor of Pharmacy Association) and PAAi (Patent Agent Association). Workshop is being organized by Dr. Shivraj Dasari, CSO of SLS Cell Culture Technologies Pvt. Ltd at this esteemed scientific conference
and this event will boost your industry knowledge and enhance
relationships by networking between industrialists and academic leaders.
Bio waivers & Biosimilars International Conference 2013 was
supported by BioPort Folio (USA), ChemLinked (China) & Lab Bulletin (USA) and our Event exhibitor: FeF Chemicals, Denmark.
Conference Highlights
- Challenges and Regulatory Approach for Biosimilars
- Emerging Biosimilars in Therapeutics
- Clinical Studies and Clinicians Prospects for Biosimilars
- Globalization of Biosimilars
- Biosimilars Innovator Pharmaceutical Products
- Analytical Strategies
- Bioequivalence Assessment
- BCS and IVIVC Based Biowaivers
- Plant Produced Biosimilar Products
- Pharmacovigilance and its Challenges
Biosimilars International Conference-2014
provides an in-depth discussion of key industry issues essential to
biosimilars including cost effectual development and progression of
methods, operation of clinical trials, appraising safety and quality,
key strategies for dissolution testing, overcoming regulatory and legal
issues and achieving access to emerging markets and commercialising
biosimilars. The conference also covers the chief advancements of
biowaivers. The world biosimilar monoclonal antibody (mAbs) market will
produce $3,229m in 2018. Pharmaceutical Conferences
Asia organized by OMICS Group Scientific Conferences includes the
exhibitions, symposium, workshops. OMICS Group Conferences also
organizes the poster competitions and young researcher forum in
Biowaivers & Biosimilars International Conference 2014 to encourage
the budding scientists and graduate students. OMICS group aims to
inspire and share the ideas of the entrepreneurs to proceed more rapidly
for further research in Biosimilars and related sessions like Emerging
therapeutics in Biosimilars and Bioequivalence assessment. Biowaivers
& Biosimilars International Conference 2014 encourage and explore
the thesis of research study in the field of Biosimilars and BABE
studies.
Mark your calendars now and be part of this biosimilars conference going to be organized in India, to associate; exchange ideas and expand knowledge as we discover the future opportunities of Biosimilars in 2014!
All accepted abstracts will be published in respective OMICS Group Journals.
Abstracts will be provided with Digital Object Identifier by Cross Ref.
Operated by Editors of: Journal of Bioanalysis & Biomedicine | Journal of Bioequivalence & Bioavailability
No comments:
Post a Comment